Can we precisely classify liver fibrosis without biopsy in hepatitis C?

摘要

The prognosis of patients with chronic hepatitis C (CHC) is closely linked to the progression of liver fibrosis [1]. Indications for antiviral therapy, achievement of sustained viral response under treatment and the need for screening for hepatocellular carcinoma or large esophageal varices are also related to the amount of liver fibrosis. Thus, a precise evaluation of liver fibrosis is mandatory for the management of CHC patients.